XML 37 R21.htm IDEA: XBRL DOCUMENT
v3.20.4

Acquisition and Other Expense | 12 Months Ended
--- | ---
Dec. 31, 2020
Acquisition and Other Expense [Abstract] |
Acquisition and Other Expense [Text Block] | Acquisition and Other Expense Acquisition and other expense for the year ended December 31, consists of the following:
| 2020 |  | 2019 |  | 2018
Plant underutilization costs | $ | 6,586 |  |  | $ | — |  |  | $ | — |
Manufacturing consolidation costs | 3,993 |  |  | 2,858 |  |  | — |
Acquisition and integration costs | 2,820 |  |  | 1,335 |  |  | — |
Product rationalization costs - inventory | 2,169 |  |  | — |  |  | — |
Restructuring costs | 1,087 |  |  | — |  |  | — |
Acquisition and other expense included in cost of sales | $ | 16,655 |  |  | $ | 4,193 |  |  | $ | — |
Restructuring and related costs | $ | 4,782 |  |  | $ | — |  |  | $ | — |
Product rationalization costs - field inventory | 2,095 |  |  | — |  |  | — |
Acquisition and integration costs | 1,192 |  |  | 13,066 |  |  | 2,372 |
Acquisition and other expense included in selling and administrative expense | $ | 8,069 |  |  | $ | 13,066 |  |  | $ | 2,372 |
Impairment charges included in research and development expense | $ | — |  |  | $ | — |  |  | $ | 4,212 |
Debt refinancing costs included in other expense | $ | — |  |  | $ | 3,904 |  |  | $ | — |
During 2020, we recorded a $6.6 million charge to cost of sales related to plant underutilization due to abnormally low production as a result of decreased sales caused by the COVID-19 pandemic. During 2020, we incurred $4.0 million in costs related to the consolidation of certain manufacturing operations which were charged to cost of sales. These costs related to winding down operations at certain locations and moving production lines to other facilities. During 2019, we incurred $2.9 million in severance and other costs related to the consolidation of certain manufacturing operations. These costs were charged to cost of sales. During 2020, we recognized costs for inventory step-up adjustments and other costs related to a previous acquisition of $2.8 million. During 2019, we incurred $1.3 million in costs for inventory adjustments and other costs associated with the acquisition of Buffalo Filter as further described in Note 2. These costs were charged to cost of sales. During 2020, we performed an analysis of our product lines and determined certain catalog numbers, principally related to capital equipment, would be discontinued and consolidated into existing product offerings. We consequently recorded a $2.2 million charge to cost of sales to write-off inventory of the discontinued products. In addition, we incurred $2.1 million in costs related to the write-off of field inventory used for customer demonstration and evaluation of the discontinued products which we charged to selling and administrative expense. During 2020, we incurred $1.1 million in restructuring costs related to a voluntary separation arrangement with employees as a result of the COVID-19 pandemic which were charged to cost of sales based on the job function of the affected employees. Substantially all of the costs associated with the voluntary separation arrangement were paid during 2020. During 2020, we recorded a charge of $3.8 million related to the restructuring of our sales force which was charged to selling and administrative expense. The charges for sales force restructuring consisted primarily of termination payments to Orthopedic distributors made in exchange for ongoing assistance to transition to employee-based sales representatives and severance. During 2020, we recorded $0.9 million in restructuring charges principally related to a voluntary separation arrangement with employees as a result of the COVID-19 pandemic which were charged to selling and administrative expense based on the nature of the costs and function of the affected employees. Substantially all of the costs associated with the voluntary separation arrangement were paid during the year. During 2020, 2019 and 2018, we incurred $1.2 million, $13.1 million and $1.3 million in costs associated with the February 11, 2019 acquisition of Buffalo Filter as further described in Note 2 that were included in selling and administrative expense. These costs include investment banking fees, consulting fees, legal fees, severance and integration related costs. During 2018 we incurred $1.1 million in cost associated with a prior acquisition and were also included in selling and administrative expense. The cost consists of a charge to selling and administrative expense associated with a vacant lease related to the acquisition. During 2018, we recorded a net charge of $4.2 million to research and development expense mainly associated with the impairment of an in-process research and development asset, net of the release of previously accrued contingent consideration in other current and long-term liabilities, as further described in Note 13. During 2019, we incurred a $3.6 million charge related to commitment fees paid to certain of our lenders, which provided a financing commitment for the Buffalo Filter acquisition and recorded a loss on the early extinguishment of debt of $0.3 million in conjunction with the sixth amended and restated senior credit agreement as further described in Note 7.

X
- Definition Acquisition and Other Expense [Abstract] + References No definition available. + Details
Name: | cnmd_AcquisitionandOtherExpenseAbstract
Namespace Prefix: | cnmd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Acquisition and Other Expense [Text Block] + References No definition available. + Details
Name: | cnmd_AcquisitionandOtherExpenseTextBlock
Namespace Prefix: | cnmd_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration